BlossomHill Therapeutics, Inc. (BLSM)

BlossomHill Therapeutics Statistics

Total Valuation

BLSM has a market cap or net worth of $501.02 million. The enterprise value is $408.04 million.

Market Cap	501.02M
Enterprise Value	408.04M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BLSM has 30.64 million shares outstanding.

Current Share Class	30.64M
Shares Outstanding	30.64M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+8.07%
Owned by Insiders (%)	11.59%
Owned by Institutions (%)	10.46%
Float	19.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.79
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.40, with a Debt / Equity ratio of 0.22.

Current Ratio	7.40
Quick Ratio	7.17
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-58.69%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.13M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	670,388

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-74.68M
Pretax Income	-71.09M
Net Income	-71.09M
EBITDA	-74.20M
EBIT	-74.68M
Earnings Per Share (EPS)	-$28.59

Balance Sheet

The company has $116.00 million in cash and $23.02 million in debt, with a net cash position of $92.98 million or $3.03 per share.

Cash & Cash Equivalents	116.00M
Total Debt	23.02M
Net Cash	92.98M
Net Cash Per Share	$3.03
Equity (Book Value)	104.70M
Book Value Per Share	-57.53
Working Capital	103.55M

Cash Flow

In the last 12 months, operating cash flow was -$56.89 million and capital expenditures -$678,000, giving a free cash flow of -$57.56 million.

Operating Cash Flow	-56.89M
Capital Expenditures	-678,000
Depreciation & Amortization	481,000
Net Borrowing	n/a
Free Cash Flow	-57.56M
FCF Per Share	-$1.88

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BLSM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-14.19%
FCF Yield	-11.49%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial statistics are provided by S&P Global Market Intelligence. Financial numbers update within hours after each earnings release, while price-based statistics and ratios update throughout each trading day.

Update frequency:

Daily

Last checked:

Aug 14, 2026

Data Sources Report a data error